ALX Oncology Holdings (ALXO) Earnings Date & Reports

Get AI intraday signals

A.I. Advisor

published Earnings

ALXO is expected to report earnings to rise 17.24% to -68 cents per share on March 06

ALX Oncology Holdings ALXO Stock Earnings Reports

Q4'24

Est.

$-0.68

Q3'24

Beat

by $0.20

Q2'24

Missed

by $0.02

Q1'24

Beat

by $0.11

Q4'23

Missed

by $0.05

The last earnings report on November 08 showed earnings per share of -57 cents, beating the estimate of -77 cents. With 2.14M shares outstanding, the current market capitalization sits at 94.41M.

View a ticker or compare two or three

Compare

ALXO

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ALXO
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a clinical stage company, which engages in the research and development of therapies for cancer patients

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

323 Allerton Avenue

Phone

+1 650 466-7125

Employees

Web

https://www.alxoncology.com